A detailed history of Kornitzer Capital Management Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 135,482 shares of LGND stock, worth $15.4 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
135,482
Previous 135,482 -0.0%
Holding current value
$15.4 Million
Previous $11.4 Million 18.89%
% of portfolio
0.26%
Previous 0.22%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$65.67 - $77.08 $1.89 Million - $2.21 Million
28,730 Added 26.91%
135,482 $9.97 Million
Q4 2022

Feb 02, 2023

SELL
$61.72 - $96.74 $1.17 Million - $1.83 Million
-18,940 Reduced 15.07%
106,752 $7.13 Million
Q3 2022

Nov 03, 2022

SELL
$0.01 - $107.56 $947 - $10.2 Million
-94,730 Reduced 42.98%
125,692 $10.8 Million
Q2 2022

Aug 03, 2022

SELL
$74.52 - $117.06 $6.19 Million - $9.72 Million
-83,000 Reduced 27.35%
220,422 $19.7 Million
Q3 2021

Nov 03, 2021

SELL
$102.33 - $144.73 $3.35 Million - $4.74 Million
-32,775 Reduced 9.75%
303,422 $42.3 Million
Q2 2021

Jul 30, 2021

SELL
$113.03 - $155.64 $7.75 Million - $10.7 Million
-68,578 Reduced 16.94%
336,197 $44.1 Million
Q1 2021

Apr 30, 2021

SELL
$99.52 - $215.83 $3.62 Million - $7.86 Million
-36,415 Reduced 8.25%
404,775 $61.7 Million
Q4 2020

Jan 29, 2021

BUY
$80.55 - $106.05 $3.06 Million - $4.03 Million
38,040 Added 9.44%
441,190 $43.9 Million
Q3 2020

Oct 30, 2020

BUY
$89.56 - $126.72 $4.08 Million - $5.77 Million
45,570 Added 12.74%
403,150 $38.4 Million
Q2 2020

Aug 03, 2020

BUY
$68.28 - $123.65 $14.8 Million - $26.9 Million
217,405 Added 155.1%
357,580 $40 Million
Q1 2020

Apr 30, 2020

BUY
$63.37 - $107.88 $2.15 Million - $3.65 Million
33,880 Added 31.87%
140,175 $10.2 Million
Q4 2019

Jan 31, 2020

SELL
$96.94 - $113.59 $1.11 Million - $1.3 Million
-11,468 Reduced 9.74%
106,295 $11.1 Million
Q3 2019

Nov 04, 2019

BUY
$86.25 - $120.16 $603,750 - $841,120
7,000 Added 6.32%
117,763 $11.7 Million
Q2 2019

Jul 31, 2019

SELL
$107.38 - $129.34 $503,612 - $606,604
-4,690 Reduced 4.06%
110,763 $12.6 Million
Q1 2019

May 01, 2019

BUY
$105.93 - $142.47 $2.4 Million - $3.23 Million
22,684 Added 24.45%
115,453 $14.5 Million
Q4 2018

Jan 31, 2019

BUY
$128.36 - $272.13 $3.59 Million - $7.6 Million
27,937 Added 43.09%
92,769 $12.6 Million
Q3 2018

Nov 13, 2018

SELL
$211.18 - $274.49 $1.99 Million - $2.58 Million
-9,400 Reduced 12.66%
64,832 $17.8 Million
Q2 2018

Aug 02, 2018

SELL
$150.77 - $207.98 $149,714 - $206,524
-993 Reduced 1.32%
74,232 $15.4 Million
Q1 2018

Apr 30, 2018

SELL
$138.63 - $182.62 $2.66 Million - $3.5 Million
-19,160 Reduced 20.3%
75,225 $12.4 Million
Q4 2017

Jan 31, 2018

SELL
$128.36 - $147.04 $550,664 - $630,801
-4,290 Reduced 4.35%
94,385 $12.9 Million
Q3 2017

Oct 31, 2017

BUY
$120.91 - $137.94 $11.9 Million - $13.6 Million
98,675
98,675 $13.4 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.